Show results for
Refine by
Colon Product Applications In Europe
2 applications found
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an assessment of the tumor immune response. ...
ByVeracyte based in Marseille Cedex 9, FRANCE
Colorectal cancer is the third most commonly occurring cancer in men and the second most commonly occurring cancer in women. There were over 1.8 million new cases worldwide in 2018. Generally colorectal cancer is being treated with surgery by cutting away the diseased part in the rectum and joining the two new ends together resulting in an anastomosis (which is the resultant ...
BySafeHeal based in Paris, FRANCE